CoChat

A small-molecule inhibitor of Tcf/β-catenin signaling down-regulates PPARγ and PPARδ activities

Handeli, Shlomo, Simon, Julian A. · 2008 · Molecular Cancer Therapeutics

The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.

Abstract

Activation of the Wnt/β-catenin signaling pathway occurs in several types of cancers and thus it is an attractive target for anticancer drug development. To identify compounds that inhibit this pathway, we screened a chemical library using a cell-based β-catenin/Tcf–responsive reporter. We identified FH535, a compound that suppresses both Wnt/β-catenin and peroxisome proliferator–activated receptor (PPAR) signaling. FH535 antagonizes both PPARγ and PPARδ ligand–dependent activation and shows structural similarity to GW9662, a known PPARγ antagonist. The effect of FH535 on β-catenin/Tcf activity is reduced in cells carrying a deletion of the PPARδ gene, as well as by the PPARγ agonist lysophosphatidic acid. Mechanistically, FH535 inhibits recruitment of the coactivators β-catenin and GRIP1 but not the corepressors NCoR and SMRT. Its repression of β-catenin recruitment, in comparison with GW9662, is linked to FH535′s unique capability to inhibit the Wnt/β-catenin signaling pathway. The antiproliferation effect of the compound observed on some transformed colon lung and liver cell lines is suggestive of its potential therapeutic value in the treatment of cancer. [Mol Cancer Ther 2008;7(3):521–9]

Overview

Integrity signals

Registry

Crossref · 10.1158/1535-7163.mct-07-2063

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 45 references

Cited by

See all 192

Metadata

Authors
Handeli, S., & Simon, J. A.
Affiliations
Fred Hutch Cancer Center (US)
Venue
Molecular Cancer Therapeutics
Published
2008-03-01
Volume
7
Issue
3
Pages
521-529
ISSN
  • 1535-7163 (ISSN-L)
  • 1538-8514
OpenAlex
W2120269934
Cited by
183
References
46
Citations by year
2026: 2 · 2025: 6 · 2024: 11 · 2023: 6 · 2022: 7 · 2021: 13 · 2020: 11 · 2019: 13 · 2018: 17 · 2017: 17 · 2016: 16 · 2015: 12 · 2014: 13 · 2013: 12 · 2012: 12
FWCI
1.92
Type
journal article
Language
en
Open access
closed
Locations
  • Molecular Cancer Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords
FH535, Wnt/β-catenin signaling, PPARγ, PPARδ, small molecule inhibitors, GW9662, lysophosphatidic acid, coactivator recruitment, GRIP1, NCoR, SMRT, antiproliferative activity, anticancer drug development, colon cancer, lung cancer, liver cancer
MeSH terms
Base Sequence, Cell Line, Humans, Lysophospholipids, Sulfonamides, Signal Transduction, DNA Primers, PPAR delta, PPAR gamma, beta Catenin, TCF Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A small-molecule inhibitor of Tcf/β-catenin signaling down-regulates PPARγ and PPARδ activities. https://app.cochat.ai/papers/10.1158/1535-7163.mct-07-2063
The paper
Handeli, S., & Simon, J. A. (2008). A small-molecule inhibitor of Tcf/β-catenin signaling down-regulates PPARγ and PPARδ activities. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-07-2063

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.